BUYINS.NET: ACTS, GBLI, OPTR, CQP, VAW, LPTH ARE SEASONALLY RIPE TO GO DOWN IN THE NEXT FIVE WEEKS – Zacks.com

In addition, the companys other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic for the treatment of upper and lower respiratory tract infections; OPT-88, a disease-modifying intra-articular therapy for …

Leave a Reply

Your email address will not be published.